New Two-Drug combo challenges standard Four-Drug treatment for stomach bug
NCT ID NCT05647278
Summary
This study tested whether a simpler two-drug treatment works as well as the standard four-drug treatment for eliminating H. pylori stomach bacteria. Researchers compared a new acid-reducing drug called Tegoprazan plus amoxicillin against the standard four-drug regimen in 370 adults with their first H. pylori infection. The goal was to see if the simpler treatment could effectively clear the infection while being easier for patients to take.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hangzhou first people's Hospital
Hangzhou, Zhejiang, 310000, China
Conditions
Explore the condition pages connected to this study.